Drug Type Radiolabeled antibody, Diagnostic radiopharmaceuticals |
Synonyms 99mTc-Sulesomab, Immunoglobulin G1 (mouse monoclonal IMMU-MN3 Fab' fragment gamma-chain anti-human NCA-90 granulocyte cell antigen), disulfide with mouse monoclonal IMMU-MN3 light chain, ImmuRAID MN3 Tc 99m + [3] |
Target |
Action inhibitors |
Mechanism CEACAM6 inhibitors(Carcinoembryonic antigen related cell adhesion molecule 6 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date European Union (14 Feb 1997), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D05944 | 99mTc-Sulesomab |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetic foot ulcer | European Union | 14 Feb 1997 | |
Diabetic foot ulcer | Iceland | 14 Feb 1997 | |
Diabetic foot ulcer | Liechtenstein | 14 Feb 1997 | |
Diabetic foot ulcer | Norway | 14 Feb 1997 | |
Osteomyelitis | European Union | 14 Feb 1997 | |
Osteomyelitis | Iceland | 14 Feb 1997 | |
Osteomyelitis | Liechtenstein | 14 Feb 1997 | |
Osteomyelitis | Norway | 14 Feb 1997 |
Not Applicable | 53 | 99m Tc-sulesomab | xmiirnxhbl(ayeykmzvwf) = nllardyyyo bdiacdegil (ylxezrlika ) View more | Positive | 11 Sep 2017 | ||
99m Tc-nanocolloid | xicepsrizl(mjnibtdrrk) = qohoquhevc gnxbhepmew (rxokneiksc ) View more | ||||||
Not Applicable | 55 | kdwbbuuuop(yehdearrpv) = cyrrjkddrj ntpxjgwupk (fzgkanlfoq ) View more | Positive | 21 Sep 2016 |